Supplemental material
Cancer Biology & Therapy
Volume 19, 2018 - Issue 11
Related Research Data
Sequencing of ALK Inhibitors in ALK+ Non-Small Cell Lung Cancer
Source:
Springer Science and Business Media LLC
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
Source:
Massachusetts Medical Society
BIRC6-ALK, a Novel Fusion Gene in ALK Break-Apart FISH-Negative Lung Adenocarcinoma, Responds to Crizotinib.
Source:
International Association for the Study of Lung Cancer. Published by Elsevier Inc.
Identification of a novel crizotinib-sensitive BCL11A-ALK gene fusion in a nonsmall cell lung cancer patient.
Source:
European Respiratory Society (ERS)
KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer
Source:
American Association for Cancer Research (AACR)
Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
Source:
Massachusetts Medical Society
Fusion of a Coiled‐Coil Domain Facilitates the High‐Level Production of Catalytically Active Enzyme Inclusion Bodies
Source:
Wiley
Global Cancer Statistics, 2012
Source:
Wiley
Global Patterns of Cancer Incidence and Mortality Rates and Trends
Source:
American Association for Cancer Research (AACR)
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization
Source:
Alphamed Press
Genomic alterations in lung adenocarcinoma
Source:
Elsevier BV
Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers
Source:
American Association for the Advancement of Science (AAAS)
KIF5B-ALKin NSCLC
Source:
Wiley
KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only.
Source:
Public Library of Science (PLoS)
Tyrosine kinase gene rearrangements in epithelial malignancies
Source:
Springer Science and Business Media LLC
Detection of EML4-ALK fusion gene and features associated with EGFR mutations in Chinese patients with non-small-cell lung cancer.
Source:
Informa UK Limited
Differential crizotinib response duration among ALK fusion variants in ALK-positive non–small-cell lung cancer
Source:
AME Publishing Company
Unique molecular features and clinical outcomes in young patients with non-small cell lung cancer harboring ALK fusion genes
Source:
Springer Science and Business Media LLC
Linking provided by
